SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'R78'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U5K_A_08JA1_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 4 / 8 | VAL A 30LEU A 35LEU A 37ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 (-3.3A) | 0.54A | 3u5kA-6cw0A:16.7 | 3u5kA-6cw0A:26.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U5K_B_08JB2_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 4 / 7 | VAL A 30LEU A 35LEU A 37ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 (-3.3A) | 0.49A | 3u5kB-6cw0A:16.7 | 3u5kB-6cw0A:26.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U5K_C_08JC3_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 4 / 8 | VAL A 30LEU A 35LEU A 37ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 (-3.3A) | 0.53A | 3u5kC-6cw0A:16.9 | 3u5kC-6cw0A:26.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A9J_A_TYLA1188_1 (BROMODOMAINCONTAINING 2) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 4 / 5 | VAL A 30LEU A 35LEU A 37ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 (-3.3A) | 0.64A | 4a9jA-6cw0A:17.5 | 4a9jA-6cw0A:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A9J_B_TYLB1187_1 (BROMODOMAINCONTAINING 2) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 4 / 5 | VAL A 30LEU A 35LEU A 37ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 (-3.3A) | 0.66A | 4a9jB-6cw0A:17.8 | 4a9jB-6cw0A:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A9J_C_TYLC1184_1 (BROMODOMAINCONTAINING 2) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 4 / 5 | VAL A 30LEU A 35LEU A 37ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 (-3.3A) | 0.65A | 4a9jC-6cw0A:17.9 | 4a9jC-6cw0A:23.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A9K_A_TYLA2200_1 (CREB-BINDING PROTEIN) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 5 / 6 | VAL A 30LEU A 35TYR A 82ASN A 83VAL A 89 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)UNX A 203 ( 4.1A)R78 A 201 (-3.3A)UNX A 205 ( 4.1A) | 0.47A | 4a9kA-6cw0A:17.9 | 4a9kA-6cw0A:38.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A9K_B_TYLB2198_1 (CREB-BINDING PROTEIN) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 4 / 5 | VAL A 30LEU A 35ASN A 83VAL A 89 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)R78 A 201 (-3.3A)UNX A 205 ( 4.1A) | 0.53A | 4a9kB-6cw0A:18.1 | 4a9kB-6cw0A:38.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5PBE_A_TYLA2001_1 (BROMODOMAIN ADJACENTTO ZINC FINGERDOMAIN PROTEIN 2B) |
4py6 | BROMODOMAIN PROTEIN,PUTATIVE (Plasmodiumfalciparum) | 4 / 6 | VAL A1221TYR A1235ASN A1278ILE A1287 | R78 A1401 ( 4.6A)R78 A1401 ( 4.9A)R78 A1401 (-3.2A)R78 A1401 (-4.1A) | 0.73A | 5pbeA-4py6A:15.2 | 5pbeA-4py6A:27.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Y1Y_A_HNQA201_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4py6 | BROMODOMAIN PROTEIN,PUTATIVE (Plasmodiumfalciparum) | 4 / 8 | VAL A1221CYH A1274ASN A1278ILE A1287 | R78 A1401 ( 4.6A)R78 A1401 ( 4.1A)R78 A1401 (-3.2A)R78 A1401 (-4.1A) | 0.60A | 5y1yA-4py6A:14.5 | 5y1yA-4py6A:30.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y1Y_A_HNQA201_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
5tcm | UNCHARACTERIZEDPROTEIN (Leishmaniadonovani) | 5 / 8 | VAL A 30LEU A 37CYH A 83TYR A 86ASN A 87 | R78 A 201 (-4.4A)NoneR78 A 201 ( 3.9A)R78 A 201 (-4.5A)R78 A 201 (-3.4A) | 0.78A | 5y1yA-5tcmA:11.5 | 5y1yA-5tcmA:25.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y1Y_A_HNQA201_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
6cw0 | CGD2_2690 PROTEIN (Cryptosporidiumparvum) | 6 / 8 | VAL A 30LEU A 35LEU A 37CYH A 79TYR A 82ASN A 83 | R78 A 201 (-4.5A)R78 A 201 (-4.9A)NoneR78 A 201 ( 3.8A)UNX A 203 ( 4.1A)R78 A 201 (-3.3A) | 0.35A | 5y1yA-6cw0A:16.9 | 5y1yA-6cw0A:28.00 |